BCR and ovarian benign neoplasm: To systematically investigate differential clonal CDR3 expression in TCR repertoires between patients with malignant and benign ovarian tumors, all 4,741,689 TCR CDR3 clones were filtered against 117,600,502 BCR clones to exclude low-expression clones.